Oncology (all articles)
Cohort Study | ICU admission for solid cancer patients treated with immune checkpoint inhibitors
8 May, 2023 | 12:53h | UTC
RCT | Bacterial decolonization for prevention of radiation dermatitis
8 May, 2023 | 12:46h | UTCBacterial Decolonization for Prevention of Radiation Dermatitis: A Randomized Clinical Trial – JAMA Oncology (free for a limited period)
News Release: A Simple Antibacterial Treatment Solves a Severe Skin Problem Caused by Radiation Therapy – Montefiore Einstein Cancer Center
Commentary on Twitter
Rand trial of 75 pts w/breast cancer + 2 with head/neck cancer showed no pts treated w/bacterial decolonization (BD) developed >gr 1 acute rad'n dermatitis (ARD), vs 24% of pts treated with standard of care, suggesting BD may be preventive vs ARD. https://t.co/6FAFH9kMt1 #RadOnc
— JAMA Oncology (@JAMAOnc) May 4, 2023
RCT | Adding Bevacizumab to trifluridine–tipiracil enhances overall survival in refractory metastatic colorectal cancer
5 May, 2023 | 15:13h | UTCTrifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
Among patients with metastatic colorectal cancer, treatment with trifluridine–tipiracil plus bevacizumab as third-line therapy resulted in longer overall survival than trifluridine–tipiracil alone (SUNLIGHT trial). https://t.co/C4DZvyiZiD pic.twitter.com/gHTR9jbJS5
— NEJM (@NEJM) May 3, 2023
21-y clinical trial update | Effects of a PSA–based screening on morbidity and mortality of prostate cancer
5 May, 2023 | 14:56h | UTC
Review | Updated salivary gland immunohistochemistry
5 May, 2023 | 14:55h | UTCUpdated Salivary Gland Immunohistochemistry: A Review – Archives of Pathology & Laboratory Medicine
Enhanced recovery after surgery (ERAS) society guidelines for gynecologic oncology: addressing implementation challenges
5 May, 2023 | 14:53h | UTC
ASTRO/ESTRO Guideline | Treatment of oligometastatic non-small cell lung cancer
4 May, 2023 | 13:44h | UTC
Commentary on Twitter
ASTRO & ESTRO partnered to issue the first guideline on local therapy for oligometastatic lung cancer, out today in #PracticalRadOnc https://t.co/ZiM2RWX394 @ESTRO_RT @IyengarPuneeth @Mat_Guc pic.twitter.com/5DV3fRdn1o
— ASTRO (@ASTRO_org) April 25, 2023
Clinical Trial Update | Adjuvant Osimertinib for resected EGFR-mutated stage IB-IIIA non–small-cell lung cancer
4 May, 2023 | 13:33h | UTCOriginal Study: Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer – New England Journal of Medicine
News Release: Trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer – Yale University
AUA/SUO Guideline | Part I – Early detection of prostate cancer: prostate cancer screening
2 May, 2023 | 13:49h | UTC
AUA/SUO Guideline | Part II – Early detection of prostate cancer: considerations for a prostate biopsy
2 May, 2023 | 13:47h | UTC
AUA/SUO Guideline | Diagnosis and management of non-metastatic upper tract urothelial carcinoma
2 May, 2023 | 13:44h | UTC
AUA/SUO Guideline | Updates to Advanced Prostate Cancer
2 May, 2023 | 13:46h | UTCUpdates to Advanced Prostate Cancer: AUA/SUO Guideline (2023) – The Journal of Urology
RCT | Efficacy and safety of intraoperative hyperthermic intraperitoneal chemotherapy for locally advanced colon cancer
2 May, 2023 | 13:36h | UTCEfficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Invited Commentary: Heated Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer–Restarting the Fire – JAMA Surgery (free for a limited period)
Commentary on Twitter
Hyperthermic intraperitoneal chemotherapy with mitomycin C along with complete cytoreduction improved locoregional control in patients with locally advanced colorectal cancer and should be considered for treatment of locally advanced colorectal cancer. https://t.co/hOM4TvgILB
— JAMA Surgery (@JAMASurgery) April 26, 2023
Cohort Study | Infection-unrelated cancers are increasingly more common than infection-related cancers among individuals with HIV
2 May, 2023 | 13:32h | UTCAge and Cancer Incidence in 5.2 Million People With Human Immunodeficiency Virus (HIV): The South African HIV Cancer Match Study – Clinical Infectious Diseases (free for a limited period)
Commentary: Infection-Unrelated Cancers Predominant Among Older Adults With HIV – Cancer Therapy Advisor
Commentary on Twitter
https://twitter.com/CIDJournal/status/1652800748105637888
Clinical trial 2y update | Avelumab first-line maintenance for advanced urothelial carcinoma
2 May, 2023 | 13:30h | UTCOriginal Article: Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma – New England Journal of Medicine
Review | Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma
28 Apr, 2023 | 13:03h | UTC
Single-arm trial | Retroperitoneal lymph node dissection as first-line treatment for early metastatic seminoma shows 81% 2-Year RFS
28 Apr, 2023 | 13:02h | UTCCommentary: Retroperitoneal Lymph Node Dissection for Early Metastatic Testicular Seminoma – The ASCO Post
M-A | Immune checkpoint inhibitors vs. chemotherapy in the 2nd-line treatment of advanced esophageal squamous cell carcinoma
28 Apr, 2023 | 12:56h | UTC
Guideline | Significance of the comprehensive geriatric assessment in the administration of chemotherapy to older adults with cancer
28 Apr, 2023 | 12:43h | UTC
ASCO Guideline Update | Management of anxiety and depression in adult survivors of cancer
26 Apr, 2023 | 14:27h | UTCCommentary: ASCO Updates Guideline for Management of Anxiety and Depression in Adult Cancer Survivors – ASCO Daily News
Related: Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline – ESMO Open
Commentary on Twitter
Just issued: Guideline update on the management of anxiety and depression in adult #CancerSurvivors. Read more ➡️ https://t.co/gxv0I86jHX #survonc #supponc #psyonc pic.twitter.com/hwnNgTuqSo
— ASCO (@ASCO) April 20, 2023
ESMO Guideline | Anxiety and depression in adult cancer patients
26 Apr, 2023 | 14:26h | UTCAnxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline – ESMO Open
Opinion | Precision palliative care as a pragmatic solution for a care delivery problem
26 Apr, 2023 | 14:19h | UTC
Commentary from the author on Twitter (thread – click for more)
In the @JCO_ASCO‼️‼️, @ravi_b_parikh & I make the case for 🎯"Precision Palliative Care" 🎯as a pragmatic solution for a care delivery problem
A 🧵
Article https://t.co/1mYcaVIov4 pic.twitter.com/5Kj87rcuZK— Ramy Sedhom, MD, FASCO (@ramsedhom) April 22, 2023
Review | Cancer treatment-related cardiovascular toxicity in gynecologic malignancies
26 Apr, 2023 | 14:14h | UTC
Commentary on Twitter
A comprehensive #JACCCardioOnc state-of-the-art review of cancer treatment-related cardiovascular toxicity in gynecologic malignancies: https://t.co/24sFcHfyPf#GynOnc #GynCSM #CardioOnc #cardiotoxicity #CardioTwitter @emorywomenheart @sdent_duke pic.twitter.com/kzqILRzuwz
— JACC Journals (@JACCJournals) April 20, 2023
ESMO Guideline | Prognostic evaluation in patients with advanced cancer in the last months of life
26 Apr, 2023 | 14:07h | UTC
Cohort Study | Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer
26 Apr, 2023 | 14:05h | UTCNews Release: Previous cancer linked to long term heightened risk of CVD – BMJ Newsroom